Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Quotient Therapeutics logo — company profile

Quotient Therapeutics

Founded 2022 United States Cambridge, United States 76 employees Seed Total: $50.00M Biotechnology, Life Sciences

General Information

Company Name Quotient Therapeutics
Founded Year 2022
Location United States Cambridge, United States
Employees 76
Industries Biotechnology, Life Sciences
Funding Stage Seed
Business Model B2B, Platform
Revenue Model Licensing, Project Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Quotient Therapeutics. To contact Quotient Therapeutics, visit quotient-tx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Quotient Therapeutics

Quotient Therapeutics, established in 2022, is a pioneering entity in the Biotechnology and Life Sciences sectors. The company is headquartered in the United States and focuses on transforming somatic genomics insights into breakthrough medicines.

Recently, Quotient Therapeutics attracted significant attention with a $50.00M investment in their Seed Round, secured from Flagship Pioneering on 21 November 2023. This investment underscores the confidence investors have in their innovative approach and potential to impact the medical field. The backing from a reputable investor like Flagship Pioneering marks a strong vote of confidence in their business model and future growth prospects.

Services & Products

Genomic Research
Therapeutic Development
R&D in Biotechnology

Target Customers

Healthcare Providers Biopharmaceutical Companies Research Institutions Healthcare Investors Patients with Genetic Disorders

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $50.00M 1
Flagship Pioneering
Flagship Pioneering
21 Nov 2023

Quotient Therapeutics Alternatives & Competitors

View All Alternatives
Quotient Therapeutics vs
LifeMine Therapeutics
LifeMine Therapeutics United States

LifeMine is a biopharmaceutical company pioneering Top-Down Drug Discovery™, a new approach that lev...

Series C
105 employees
Biotechnology, Health and Wellness
Quotient Therapeutics vs
Repertoire Immune Medicines
Repertoire Immune Medicines United States

Repertoire is a biotechnology company creating a new category of immune medicines for cancer and aut...

Series B
86 employees
Biotechnology, Health and Wellness
Quotient Therapeutics vs
Refeyn
Refeyn United Kingdom

Accelerating discovery and revolutionizing single-molecule bioanalytics with mass photometry.

Series A
166 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Quotient Therapeutics

We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com
Quotient Therapeutics was founded in 2022.
Quotient Therapeutics is headquartered in Cambridge, United States.
Quotient Therapeutics operates in Biotechnology and Life Sciences. Its customers include Healthcare Providers, Biopharmaceutical Companies and Research Institutions.
Quotient Therapeutics has a B2B and Platform business model. Its revenue comes from Licensing, Project Based and Product Sales.
Quotient Therapeutics has approximately 76 employees.
Quotient Therapeutics has completed 1 funding round, raising a total of $50.00M. The latest funding stage is Seed.
Quotient Therapeutics offers: Genomic Research, Therapeutic Development, R&D in Biotechnology.
Top alternatives and competitors to Quotient Therapeutics include LifeMine Therapeutics, Repertoire Immune Medicines, Refeyn, Vizgen, Complete Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quotient Therapeutics and LifeMine Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Quotient Therapeutics, https://bouncewatch.com/company/quotient-therapeutics, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes